ESIKA description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

ESIKA

Ventura Corporation (San Juan, P.R)

ēsika Perfect sun kids


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

Drug Facts

Active Ingredients

Ensulizole (3%), Octinoxate (7.5%), Octisalate (5%), Octocrylene (7%), Oxybenzone (6%),Titanium Dioxide (4.68%)

Purpose

Sunscreen

ESIKA Uses

  • helps prevent sunburn
  • higher SPF gives more sunburn protection

Warnings

For external use only.

When using this product

  • Keep out of eyes. Rinse with water to remove.

Stop use and ask a doctor if

  • rash and irritation develops and lasts.
  • Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

  • Apply smoothly every morning before sun exposure and as needed.
  • Children under 6 months of age: ask a doctor.

ESIKA Other information

  • High sun protection product.
  • Sun alert: Limiting sun exposure, wearing protective clothing, and using sunscreens may reduce the risk of skin aging, skin cancer, and other harmful effects of the sun.

Inactive ingredients

Aqua (water), dicaprylyl carbonate, vp/eicosene copolymer, phenethyl benzoate, arginine, cyclohexasiloxane, cetearyl alcohol, sorbitan stearate, dimethicone, glyceryl stearate, potassium cetyl phosphate, phenoxyethanol, trimethylsiloxysilicate, silica, disodium lauriminodipropionate tocopheryl phosphates, methyl methacrylate crosspolymer, methicone, methylparaben, ceteareth-20, propylparaben, xanthan gum, parfum (fragrance), cyclopentasiloxane, butylparaben, ethylparaben, isobutylparaben.

PRINCIPAL DISPLAY PANEL - 82 g Bottle Label

UVB SPF
50
High Protection
UVA

Perfect
sun
kids

protector against solar
rays for children, face and
body SPF 50

ēsika

80 g e (2.8 oz.)

ESIKA

ESIKA

ENSULIZOLE, OCTINOXATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE, and TITANIUM DIOXIDE CREAM

Product Information

Product Type Human otc drug label Item Code (Source) NDC:13537-363
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
Ensulizole Ensulizole 0.03 g
OCTINOXATE OCTINOXATE 0.075 g
OCTISALATE OCTISALATE 0.05 g
OCTOCRYLENE Octocrylene 0.07 g
OXYBENZONE OXYBENZONE 0.6 g
titanium dioxide 0.0468 g

Inactive Ingredients

Ingredient Name Strength
water
DICAPRYLYL CARBONATE
phenethyl benzoate
ARGININE
CYCLOMETHICONE 6
CETOSTEARYL ALCOHOL
SORBITAN MONOSTEARATE
DIMETHICONE
GLYCERYL MONOSTEARATE
potassium cetyl phosphate
PHENOXYETHANOL
SILICON DIOXIDE
DISODIUM LAURIMINODIPROPIONATE TOCOPHERYL PHOSPHATES
METHYLPARABEN
POLYOXYL 20 CETOSTEARYL ETHER
PROPYLPARABEN
XANTHAN GUM
CYCLOMETHICONE 5
BUTYLPARABEN
ETHYLPARABEN
isobutylparaben

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:13537-363-01 80 in 1 BOTTLE
2 NDC:13537-363-02 1 in 1 BOTTLE

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2011-05-30


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.